Colgate-Palmolive Company Dossier

Colgate-Palmolive Company generated second-quarter FY2025 net sales of $5.11 billion and an operating profit of $1.08 billion, supported by sequential improvement in organic sales momentum across its global portfolio. The organization maintained its dominant position in the oral care sector while navigating a complex macroeconomic environment through strategic pricing and volume management.

Financial Highlights

* Second Quarter 2025 Net Sales: $5.11 billion

* Second Quarter 2025 Operating Profit: $1.08 billion

* Second Quarter 2025 Diluted EPS: $0.91

* Second Quarter 2025 Gross Profit Margin: 60.1%

* First Half 2025 Free Cash Flow: $1.252 billion

* Year-to-Date Global Toothpaste Market Share: 41.1%

* Hill's Pet Nutrition Second Quarter Revenue: $1.157 billion

Strategic Analysis

Colgate-Palmolive Company demonstrated operational resilience throughout the first half of fiscal year 2025, evidenced by a sequential acceleration in organic sales growth from 1.4% in the first quarter to 1.8% in the second quarter. This performance underscores the effectiveness of the company's... Sign in / Sign up to learn more about Colgate-Palmolive Company

Continue your research by chatting with our AI financial analyst about Colgate-Palmolive Company. Ask follow-up questions, request specific analysis, or explore investment scenarios. All insights are grounded in verified financial data and SEC filings.

Start your analysis with these investor-focused questions:

• Given Colgate-Palmolive Company's FY2025 guidance for organic sales growth at the low end of 2-4%, how do the contrasting performances of its geographic segments—particularly the decline in North America versus growth in Europe—impact the strategy required to meet this full-year target?
• The Hill's Pet Nutrition segment grew 3.86% in Q2 2025 despite exiting the private label business. How does this strategic shift likely affect the segment's profitability and Colgate-Palmolive Company's overall margin profile for the remainder of FY2025?
• Colgate-Palmolive Company announced a new three-year productivity program in August 2025. What specific financial metrics in the upcoming Q3 and Q4 2025 reports will be most indicative of this program's initial success in offsetting cost inflation and supporting the company's margin guidance?
• With a forward P/E of 19.8 and a low beta of 0.34, how does Colgate-Palmolive Company's current valuation balance its defensive characteristics against the execution risks of its growth initiatives and the competitive pressures noted in the first half of FY2025?
• Considering the investment thesis, how does the mixed performance across Colgate-Palmolive Company's Oral Care segments in FY2025, such as softness in Asia Pacific versus strength in Latin America, influence the likelihood of the 'bull case' (accelerated growth) versus the 'bear case' (market share erosion) materializing?